WORLDQUANT MILLENNIUM ADVISORS LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1745981
NEW YORK, NY
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$77,780,896
+$31,967,325 QoQ
Shares Held
100,669
+69.6% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WORLDQUANT MILLENNIUM ADVISORS LLC holds $237,388,644 across 14 Biotechnology names. REGN ranks #1 (32.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
100,669 | $77,780,896 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
622,304 | $60,519,064 | |
| 3 | INCY |
Incyte Corp
|
493,713 | $46,468,267 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
42,160 | $13,949,479 | |
| 5 | EXEL |
Exelixis, Inc.
|
236,324 | $10,135,936 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
202,420 | $5,607,034 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
214,587 | $4,669,413 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
23,677 | $4,476,136 |
All Filings in REGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $77,780,896 | 100,669 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $45,813,571 | 59,354 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $37,888,001 | 67,384 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $82,323,688 | 129,801 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $75,014,759 | 105,309 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $127,489,131 | 121,275 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $432,158 | 449 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,315,678 | 1,498 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $14,138,452 | 17,180 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,909,081 | 16,574 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,826,130 | 21,695 | Shares | Defined | 2023-05-15 | |
| 2021-12-31 | $28,615,434 | 45,312 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,893,122 | 6,433 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $5,890,119 | 12,449 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $2,337,081 | 4,175 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,651,805 | 7,459 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,795,007 | 9,820 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||